Skip to main content
SpringerLink
Log in

The effect of methylprednisolone pulse therapy on methotrexate treatment of rheumatoid arthritis

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

We randomly assigned 30 active rheumatoid arthritis (RA) patients who started oral methotrexate (MTX, 7.5 mg/week) treatment, into 3 groups. Group I received no additional corticosteroids; Group II was treated with 3 oral pulses of 100 mg prednisolone and Group III with 3 intravenous pulses of 1000 mg methylprednisolone (MP) on alternate days during the first week. Parameters of disease activity were measured at the start, after 10 days and at regular intervals up to 1 year. In Group I maximal improvement occurred after 18 weeks and in Group III after 6 weeks. This effect was sustained during the study. The initial effects in Group II were not as strong as in Group III and of shorter duration. No serious side effects were noticed. Our results suggest, that MP-pulse therapy seems to be useful in bridging the gap between the introduction of MTX and the response to this drug. Furthermore, we found that patients who were HLA-DR4-positive showed a better clinical response after 1 year than HLA-DR4-negative patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weinblatt, M.E., Kaplan, H., Germain, B.F., Merriman, R.C., Solomon, S.D., Wall, B., Anderson, L., Block, S., Small, R., Wolfe, F., Gall, E., Torretti, D., Polisson, R. Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study. J Rheum 1991, 18, 334–338.

    PubMed  Google Scholar 

  2. Andersen, P.A., West, S.G., O'Dell, J.R., Via, Ch.S., Claypool, R.G., Kotzin, B.L. Weekly pulse methotrexate in rheumatoid arthritis. Ann Int Med 1985, 103, 489–496.

    PubMed  Google Scholar 

  3. Olsen, N.J., Murray, L.M. Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum 1989, 32, 378–385.

    PubMed  Google Scholar 

  4. Williams, H.J., Willkens, R.F., Samuelson, C.O. Jr., Alarcón, G.S., Guttadauria, M., Yarboro, Ch., Polisson, R.P., Weiner, S.R., Luggen, M.E., Billingsley, L.M., Dahl, S.L., Egger, M.J., Reading, J.C., Ward, J.R. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1985, 28, 721–730.

    PubMed  Google Scholar 

  5. Sambrook, P.N., Champion, G.D., Browne, C.D., Cohen, M.L., Compton, P., Day, R.O., Jager, de, J. Comparison of methotrexate with azathioprine or 6-mercaptopurine in refractory rheumatoid arthritis: a life-table analysis. Br J Rheum 1986, 25, 372–375.

    Google Scholar 

  6. Neumann, V., Hopkins, R., Dixon, J., Watkins, A., Bird, H., Wright, V. Combination therapy with pulsed methylprednisolone in rheumatoid arthritis. Ann Rheum Dis 1985, 44, 747–751.

    PubMed  Google Scholar 

  7. Bijlsma, J.W.J., Schenk, Y., Ramselaar, A.C.P., Huber-Bruning, O. Methylprednisolone pulse therapy in conjunction with azathioprine in rheumatoid arthritis. Clin Rheum 1986, 5, 499–504.

    Google Scholar 

  8. Williams, I.A., Bayliss, E.M., Shipley, M.E. A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Lancet 1982, ii, 237–240.

    Google Scholar 

  9. Forster, P.J.G., Grindulis, K.A., Neumann, V., Hubball, S., McConkey, B. High-dose intravenous methylprednisolone in rheumatoid arthritis. Ann Rheum Dis 1982, 41, 444–446.

    PubMed  Google Scholar 

  10. Ropes, M.W., Bennett, G.A., Caleb, S., Jacox, R., Jessar, R.A. Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958, 9, 175–176.

    PubMed  Google Scholar 

  11. Ritchie, D.M., Boyle, J.A., McInnes, J.M., Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quart J Med 1968, 37, 393–406.

    PubMed  Google Scholar 

  12. Stastny, P. Association of the B-cell allo-antigen DRw4 with rheumatoid arthritis. N Engl J Med 1978, 298, 869–871.

    PubMed  Google Scholar 

  13. Westedt, M.L., Breedveld, F.C., Schreuder, G.M.Th., D'Amaro, J., Cats, A., de Vries, R.R.P. Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis 1986, 45, 534–538.

    PubMed  Google Scholar 

  14. Weinstein, A. Long-term efficacy of methotrexate in rheumatoid arthritis. In: Methotrexate therapy in rheumatic disease. Ed.: Wilke, W.S., New York, Marcel Dekker, Inc., 1989, 91–101.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Rheumatology F 02.223, University Hospital Utrecht, Post-box 85500, 3508 GA, Utrecht, The Netherlands

    M. J. Van Der Veen & J. W. J. Bijlsma

Authors
  1. M. J. Van Der Veen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. W. J. Bijlsma
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Der Veen, M.J., Bijlsma, J.W.J. The effect of methylprednisolone pulse therapy on methotrexate treatment of rheumatoid arthritis. Clin Rheumatol 12, 500–505 (1993). https://doi.org/10.1007/BF02231779

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02231779

Key words

Search

Navigation